S. Landt

发表

Prognostic significance of the angiogenic factors angiogenin, endoglin and endostatin in cervical cancer.

S. Kümmel, W. Lichtenegger, J. Sehouli, 2011, Anticancer research.

Prognostic significance of angiogenic factors in uterine cervical cancer.

J. Blohmer, S. Kümmel, W. Lichtenegger, 2011, Anticancer research.

Analysis of HER2 and HER4 in Human Myocardium to Clarify the Cardiotoxicity of Trastuzumab (Herceptin™)

W. Lichtenegger, G. Schaller, S. Coupland, 2003, Breast Cancer Research and Treatment.

In vitro vascular tube formation testing as a tool for treatment individualisation in patients with cervical cancer.

S. Kümmel, J. Sehouli, I. Schwidde, 2011, Anticancer research.

Circulating vascular endothelial growth factors and their soluble receptors in pre-invasive, invasive and recurrent cervical cancer.

S. Kuemmel, J. Blohmer, W. Lichtenegger, 2009, Anticancer research.

The utility of an in vitro angiogenesis score for prognosis assessment in patients with cervical cancer.

T. Heusner, J. Blohmer, S. Kümmel, 2011, Anticancer research.

Tumor-specific correlation of tumor M2 pyruvate kinase in pre-invasive, invasive and recurrent cervical cancer.

T. Heusner, S. Kuemmel, A. Koeninger, 2010, Anticancer research.

Prostaglandin metabolising enzymes and PGE2 are inversely correlated with vitamin D receptor and 25(OH)2D3 in breast cancer.

M. Friedrich, F. Hoellen, M. Thill, 2010, Anticancer research.

Influence of a dose-dense adjuvant chemotherapy on sVCAM-1/sICAM-1 serum levels in breast cancer patients with 1-3 positive lymph nodes.

S. Kümmel, P. Schmid, F. Taran, 2011, Anticancer research.

High-frequency breast ultrasound for the detection of microcalcifications and associated masses in BI-RADS 4a patients.

M. Rezai, P. Skaane, J. Blohmer, 2011, Anticancer research.

First evaluation of the diagnostic accuracy of an automated 3D ultrasound system in a breast screening setting.

M. Rezai, S. Kümmel, J. Sehouli, 2011, Anticancer research.